$266 Million is the total value of Sio Capital Management, LLC's 62 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 120.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABC | Buy | AMERISOURCEBERGEN CORP | $25,938,000 | +101.3% | 183,334 | +120.2% | 9.74% | +128.6% |
| OGN | New | ORGANON & CO | $19,401,000 | – | 574,855 | +100.0% | 7.29% | – |
| INGN | Buy | INOGEN INC | $12,705,000 | -2.1% | 525,438 | +31.3% | 4.77% | +11.2% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $11,561,000 | +399.2% | 688,989 | +1205.2% | 4.34% | +466.8% |
| CNC | Buy | CENTENE CORP | $10,916,000 | +34.0% | 129,011 | +33.3% | 4.10% | +52.1% |
| HCA | New | HCA HEALTHCARE INC | $10,412,000 | – | 61,953 | +100.0% | 3.91% | – |
| BHC | Buy | BAUSCH HEALTH COMPANIES INCput | $8,717,000 | +3058.3% | 1,042,700 | +8517.4% | 3.27% | +3497.8% |
| NARI | Buy | INARI MEDICAL INC | $7,647,000 | +109.8% | 112,466 | +179.7% | 2.87% | +138.1% |
| BIIB | New | BIOGEN INC | $7,321,000 | – | 35,900 | +100.0% | 2.75% | – |
| MDT | New | MEDTRONIC PLC | $7,180,000 | – | 80,000 | +100.0% | 2.70% | – |
| New | SIGHT SCIENCES INC | $6,517,000 | – | 724,944 | +100.0% | 2.45% | – | |
| CAH | New | CARDINAL HEALTH INC | $6,223,000 | – | 119,061 | +100.0% | 2.34% | – |
| THC | New | TENET HEALTHCARE CORP | $5,519,000 | – | 105,000 | +100.0% | 2.07% | – |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $5,330,000 | +190.0% | 488,965 | +200.9% | 2.00% | +229.3% |
| BHVN | New | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD | $5,100,000 | – | 35,000 | +100.0% | 1.92% | – |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $4,659,000 | – | 362,294 | +100.0% | 1.75% | – |
| INBX | Buy | INHIBRX INC | $4,145,000 | +49.7% | 365,210 | +193.9% | 1.56% | +70.0% |
| UHS | New | UNIVERSAL HEALTH SERVICES INCcl b | $4,101,000 | – | 40,725 | +100.0% | 1.54% | – |
| HSKA | New | HESKA CORP | $3,739,000 | – | 39,566 | +100.0% | 1.40% | – |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $3,436,000 | +14.2% | 504,545 | +33.6% | 1.29% | +29.6% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $3,190,000 | – | 40,000 | +100.0% | 1.20% | – |
| New | MODULAR MEDICAL INC | $2,975,000 | – | 574,352 | +100.0% | 1.12% | – | |
| RXDX | New | PROMETHEUS BIOSCIENCES INCput | $2,868,000 | – | 101,600 | +100.0% | 1.08% | – |
| AGLE | Buy | AEGLEA BIO THERAPEUTICS INC | $2,358,000 | +17.7% | 4,668,536 | +435.9% | 0.89% | +33.6% |
| AFMD | Buy | AFFIMED NV | $2,274,000 | -19.2% | 821,065 | +27.6% | 0.85% | -8.3% |
| DTIL | New | PRECISION BIOSCIENCES INC | $1,614,000 | – | 1,008,993 | +100.0% | 0.61% | – |
| SVRA | Buy | SAVARA INC | $1,302,000 | +38.8% | 856,428 | +19.6% | 0.49% | +57.7% |
| Buy | TYRA BIOSCIENCES INC | $1,088,000 | -8.4% | 152,159 | +37.0% | 0.41% | +4.1% | |
| ISEE | New | IVERIC BIO INCput | $831,000 | – | 86,400 | +100.0% | 0.31% | – |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $649,000 | -67.8% | 260,448 | +0.3% | 0.24% | -63.5% |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $491,000 | -61.9% | 454,355 | +7.5% | 0.18% | -56.8% |
| ARDX | New | ARDELYX INC | $408,000 | – | 692,357 | +100.0% | 0.15% | – |
| BHC | New | BAUSCH HEALTH COMPANIES INC | $56,000 | – | 6,700 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.